Why the study?
The study investigated the occurrence of AKI and its impact on short- and long-term outcomes after aortic valve replacement in patients with AS and complex CAD.
Does a combined percutaneous approach (TAVR + PCI) compared to a surgical approach (SAVR + CABG) affect the occurrence of acute kidney injury in patients with severe aortic stenosis and complex coronary artery disease?
Does a combined percutaneous approach (TAVR + PCI) compared to a surgical approach (SAVR + CABG) affect the occurrence of acute kidney injury in patients with severe aortic stenosis and complex coronary artery disease?
In patients with severe aortic stenosis and complex coronary artery disease, combined percutaneous treatment (TAVR + PCI) results in similar rates of acute kidney injury and comparable short-term renal function compared to combined surgical treatment (SAVR + CABG).
Answers are grounded in this paper and cite their sources.
Comparable short-term renal function suggests similar AKI risk; should not yet change practice without randomized confirmation.
A single-center retrospective study was initialized to investigate the occurrence of acute kidney injury (AKI) and its impact on short- and long-term outcomes after aortic valve replacement in patients with aortic stenosis (AS) and complex coronary artery disease (CAD).Between January 2010 and December 2020, 1,232 patients with severe AS and CAD were treated. Propensity score matching generated 40 patient pairs with intermediate Society of Thoracic Surgeons (STS) risk scores (3.2 ± 0.3) and EuroSCORE II (4.1 ± 0.3) undergoing percutaneous (transcatheter aortic valve replacement [TAVR] + percutaneous coronary intervention [PCI]) or surgical (surgical aortic valve replacement [SAVR] + coronary artery bypass grafting [CABG]) combined procedures. The renal function-corrected ratio of contrast medium to body weight was calculated to determine the risk of postprocedural contrast medium-associated AKI. Renal retention values were recorded daily until the 7th day after the procedure.The overall incidence of postprocedural AKI was similar between the groups. There was no correlation between the contrast medium volume to serum creatinine to body weight ratio and AKI occurrence. During the first 7 postprocedural days, creatinine clearance values were comparable: 68.97 ± 4.92 mL/min (SAVR + CABG) vs. 64.95 ± 9.78 mL/min (TAVR + PCI), mean difference 4.02, 95% CI (-24.5 to 16.4), p = 0.691. On the 7th day after the procedure, 35% (8/23) of patients with renal impairment had improved renal function. No correlation between impaired renal function and short- or long-term mortality was found in multivariable models.Contrast agents may temporarily impair renal function during a minimally invasive percutaneous approach; however, occurrence of AKI was not related to the amount of contrast medium, and AKI was not associated with short- and long-term mortality.
No takes yet. Share an insight, caveat, or question.
Taghiyev et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: